TABLE 1.
MicroRNA (miRNA) | Thrombin-induced effects | microRNA target gene(s) | Cellular process | References |
miR-181b | ↓ | CARD10 | Endothelial cell activation | Lin et al., 2016 |
miR-181c | ↓ | MLL1 | Microglia activation | Yin et al., 2017 |
miR-146 | ↑ | CARD10 | Endothelial cell activation | Cowan et al., 2014 |
miR-146a | ↓ | NOX4 | Inflammation | Wang et al., 2014 |
miR-10b | ↑ | HOXD10 | Angiogenesis | Shen et al., 2011 |
miR-let7c | ↑ | IGF-1R | Intracerebral hemorrhage | Kim et al., 2014 |
miR-27b | ↓ | TSP-1 | Angiogenesis | Miao et al., 2018 |
miR-21 | ↑ | WASp | Inflammation, Fibrosis | Li et al., 2017; Barwari et al., 2018 |
miR-339 | ↑ | Klotho | Inflammation | Mehi et al., 2014; Li et al., 2017 |
miR-223 | ↑ | IGF-1R | Inflammation Apoptosis | Pan et al., 2014; Li et al., 2017 |
miR-24-1-5p | ↑ | PHD1 | Intracerebral hemorrhage | Cui et al., 2020 |
miR-25-3p | ↑ | ADAM10 | Inflammation | Yao et al., 2019 |
ADAM10, a disintegrin and metalloproteinase domain-containing protein 10; CARD10, caspase recruitment domain-containing protein 10; HoxD10, homeobox D10; IGF-1R, insulin-like growth factor type 1 receptor; MLL1, mixed lineage leukemia protein-1; NOX4, NADPH oxidase 4; PHD1, prolyl hydroxylase domain 1; TSP-1, thrombospondin-1; WASp, Wiskott–Aldrich syndrome protein.